Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11849329 | 0.83 | — | — | |
| SCHEMBL5242143 | 0.83 | TSHR (0.36) | TSHR | |
| SCHEMBL9065953 | 0.81 | — | — | |
| SCHEMBL137424 | 0.76 | ALDH1A1 (0.41) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL462526 | 0.73 | ALDH1A1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL777025 | 0.73 | — | — | |
| SCHEMBL252925 | 0.72 | HTT (0.35) | ALDH1A1KMT2ATSHR | |
| SCHEMBL20603229 | 0.71 | MEN1 (0.39) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL775184 | 0.70 | — | — | |
| SCHEMBL25439707 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240122877-A1 | ORAL AMPHETAMINE COMPOSITION | ADARE PHARMACEUTICALS, INC. | 2024-04-18 | — | — | US | claimed |
| US-11896562-B2 | Oral amphetamine composition | ADARE PHARMACEUTICALS, INC. (US) | 2024-02-13 | — | — | US | claimed |
| EP-3613404-B1 | METHOD FOR PRODUCING FILM | KAO CORP (JP) | 2023-09-13 | — | — | EP | claimed |
| WO-2023152773-A1 | SOLID FORMS OF MOMELOTINIB SALTS AND IMPROVED PROCESSES FOR THE PREPARATION OF MOMELOTINIB | DR. REDDY'S INSTITUTE OF LIFE SCIENCES (IN) | 2023-08-17 | — | — | WO | claimed |
| US-20230240994-A1 | MEDICAMENT-CONTAINING HOLLOW PARTICLE | Sumitomo Pharma Co., Ltd. (JP) | 2023-08-03 | — | — | US | claimed |
| US-11623920-B2 | Process for preparing pitolisant hydrochloride and solid-state forms thereof | NURAY CHEMICALS PRIVATE LIMITED (IN) | 2023-04-11 | — | — | US | claimed |
| US-20220402886-A1 | PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF | Nuray Chemicals Private Lmiited (IN) | 2022-12-22 | — | — | US | claimed |
| CN-113056262-B | Prolyl hydroxylase inhibitor pharmaceutical composition and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2022-11-18 | — | — | CN | claimed |
| CN-112641718-B | Taste-masking compound based on porous carrier and preparation method and application thereof | 山东大学 | 2022-07-29 | — | — | CN | claimed |
| US-20220160693-A1 | PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2022-05-26 | — | — | US | claimed |
| US-5382567-A | Perfumes including cyclodextrin coatings and a pH solution and gastric coating | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1995-01-17 | — | — | US | claimed |
| EP-0570606-A1 | Orally administrable solid medicine and process for preparing the same | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1993-11-24 | — | — | EP | claimed |
| US-5258375-A | Polyvinyl acetal diethylaminoacetate as a stabilizer | SS PHARMACEUTICAL CO., LTD. (JP) | 1993-11-02 | — | — | US | claimed |
| US-5244669-A | Multilayer coating | MITSUBISHI KASEI CORPORATION (JP) | 1993-09-14 | — | — | US | claimed |
| EP-0387808-B1 | COMPOSITIONS FOR THE PREPARATION OF DOSAGE-FORM ACTIVE VITAMINS D3 AND PROCESS FOR PREPARING STABLE DOSAGE-FORM ACTIVE VITAMINS D3 BY USING THE SAME | SS PHARMACEUTICAL CO., LTD. (JP) | 1993-05-12 | — | — | EP | claimed |
| EP-0387808-A2 | Compositions for the preparation of dosage-form active vitamins D3 and process for preparing stable dosage-form active vitamins D3 by using the same | SS PHARMACEUTICAL CO., LTD. (JP) | 1990-09-19 | — | — | EP | claimed |
| US-4609640-A | WATER-SOLUBLE MACROMOLECULE CHELATING AGENTS | TOYO JOZO COMPANY, LTD. (JP) | 1986-09-02 | — | — | US | claimed |
| US-4443497-A | DISSOLVING, COATING, SOLVENTS, POLYMER, ETHYL CELLULOSE, ANTICOAGULANTS, DRUGS | TANABE SEIYAKU CO., LTD. (JP) | 1984-04-17 | — | — | US | claimed |
| US-4404183-A | PARTICLE MIXTURE OF POLYOXYETHYLENE GLYCOL AND INDOMETHACIN OR NICARDIPINE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1983-09-13 | — | — | US | claimed |
| US-4343789-A | NICARDIPINE AND POLYOXYETHYLENE GLYCOL | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1982-08-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160693-A1 | PHARMACEUTICAL COMPOSITION OF PROLYL HYDROXYLASE INHIBITOR AND PREPARATION METHOD THEREFOR | P4HA1, EGLN2, EGLN3 | ALDH1A1 429/4885MEN1 2950/4885CYP1A2 290/4885 |
| US-20220402886-A1 | PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF | PITHD1, MLN, TPP1 | ALDH1A1 810/4885MEN1 1690/4885CYP1A2 322/4885 |
| US-11623920-B2 | Process for preparing pitolisant hydrochloride and solid-state forms thereof | PITHD1, MLN, TPP1 | ALDH1A1 810/4885MEN1 1690/4885CYP1A2 322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.